Cómo citar
1.
Bermúdez Salas K. Terapia de reemplazo hormonal en relación a la enfermedad de alzheimer. Rev.méd.sinerg. [Internet]. 2 de diciembre de 2016 [citado 24 de noviembre de 2024];1(12):15-20. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/55
Resumen
La menopausia es una etapa natural en la que no existe una receta o protocolo para establecer la indicación de la terapia de estrógeno. El estudio KEEPS enfatiza la necesidad de terapia de reemplazo hormonal. Es una decisión exclusiva entre el médico y el paciente, por lo que es de vital importancia como médico considerar sus implicaciones para la salud de forma individualizada.
Palabras clave
Terapia de reemplazo hormonal. estrógeno. estradiol. neurotransmisores. alzheimer.
Citas
1. Yaffe K, Sawaya G, Lieberburg I & Grady D. (1998) Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA; 279: 688-695.
2. Zandi PP, Carlson MC, Plassman BL, et al. (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. Jama; 288: 21232129.
3. Bhavnani BR. (2003) Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J Steroid Biochem Mol Biol; 85: 473-482.
4. Sherwin BB. (2009) Estrogen therapy:is time of initiation critical for neuroprotection. Nat RevEndocrinol.620-627.PubMed:19844249.
5. Daniel jM, Bohacek J. (2010) The critical period hypothesis of estrogen effects on cognition:lnsights from basic research. Biochimica et Biophysica Acta. 1800:1068-1076.
6. Erickson Kl, Voss MW, Prakash RS, et al. (2006) A cross-sectional study of hormone treatment and hippocampal volume in postmenopausal women:evidence for a limited window of opportunity. Neuropsychology. 24:68-76. PubMed:3947.
7. Wharton W, Gleason CE, Lorenze KR, et al. (2009) Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease. Amy Transi Res.2:l 31-147.
2. Zandi PP, Carlson MC, Plassman BL, et al. (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. Jama; 288: 21232129.
3. Bhavnani BR. (2003) Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J Steroid Biochem Mol Biol; 85: 473-482.
4. Sherwin BB. (2009) Estrogen therapy:is time of initiation critical for neuroprotection. Nat RevEndocrinol.620-627.PubMed:19844249.
5. Daniel jM, Bohacek J. (2010) The critical period hypothesis of estrogen effects on cognition:lnsights from basic research. Biochimica et Biophysica Acta. 1800:1068-1076.
6. Erickson Kl, Voss MW, Prakash RS, et al. (2006) A cross-sectional study of hormone treatment and hippocampal volume in postmenopausal women:evidence for a limited window of opportunity. Neuropsychology. 24:68-76. PubMed:3947.
7. Wharton W, Gleason CE, Lorenze KR, et al. (2009) Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease. Amy Transi Res.2:l 31-147.
Descargas
Los datos de descargas todavía no están disponibles.